Siemens Healthineers

Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors

Retrieved on: 
Tuesday, March 26, 2024

Mr. Pacitti is currently the President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers.

Key Points: 
  • Mr. Pacitti is currently the President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers.
  • Prior to joining Siemens Healthineers, he was Division Vice President of U.S. Commercial Operations, Sales, and Marketing at Abbott Vascular, overseeing the company’s business in North America.
  • “It’s an honor to welcome Dave to the Orchestra BioMed Board where we expect to benefit from his wealth of experience in driving the adoption of transformational device therapies and procedural imaging modalities,” said David Hochman, chairman, chief executive officer and founder of Orchestra BioMed.
  • I look forward to contributing my perspective to help Orchestra BioMed realize the full potential of its cardiovascular pipeline, strategic partnerships and differentiated business model.”

KNIME to Host Annual Spring Summit in Austin, Texas, April 15-17

Retrieved on: 
Friday, April 5, 2024

KNIME , the software company focused on making working with data intuitive, will hold its annual KNIME Spring Summit conference in Austin, Texas, April 15-17, at the AT&T Hotel and Conference Center.

Key Points: 
  • KNIME , the software company focused on making working with data intuitive, will hold its annual KNIME Spring Summit conference in Austin, Texas, April 15-17, at the AT&T Hotel and Conference Center.
  • KNIME Spring Summit offers three days of customer presentations, panels, and on-site trainings and workshops focused on using KNIME software for varying use cases across multiple industries.
  • The onsite training sessions created a momentum that would not have been possible in a virtual setting.
  • Having direct access to peers and trainers is the best way of learning.”
    For those interested in registering for the live or virtual Spring Summit, please visit knime.com/spring-summit-2024 .

Cortechs.ai Appoints Kyle Frye as New Chief Executive Officer

Retrieved on: 
Wednesday, April 3, 2024

SAN DIEGO, April 3, 2024 /PRNewswire/ -- Cortechs.ai, a leading innovator in AI applications for radiology and the developer of FDA-cleared products for the improved detection of neurodegenerative diseases and cancer, is excited to announce the appointment of Kyle Frye as its new Chief Executive Officer.

Key Points: 
  • SAN DIEGO, April 3, 2024 /PRNewswire/ -- Cortechs.ai, a leading innovator in AI applications for radiology and the developer of FDA-cleared products for the improved detection of neurodegenerative diseases and cancer, is excited to announce the appointment of Kyle Frye as its new Chief Executive Officer.
  • Prior to SyntheticMR, Kyle served as a Vice President of Sales at Siemens Healthineers, demonstrating his capability to lead high-performing teams and drive significant sales growth.
  • Kyle holds a bachelor's degree from Northern Kentucky University and is a proud resident of the Cincinnati metro area.
  • I am excited to be part of this amazing team and to be able to work closely with our customers and patients on a daily basis," said Kyle Frye.

Abcam appoints Markus Lusser as new President

Retrieved on: 
Monday, March 18, 2024

CAMBRIDGE, England, March 18, 2024 /PRNewswire/ -- Abcam today announced the appointment of Markus Lusser as President.

Key Points: 
  • CAMBRIDGE, England, March 18, 2024 /PRNewswire/ -- Abcam today announced the appointment of Markus Lusser as President.
  • A seasoned Danaher executive, Markus joins Abcam at a pivotal moment as the company transitions into the Danaher Life Sciences portfolio.
  • Prior to joining Danaher, Markus was responsible for large global commercial organizations, including 20 years at Siemens Healthineers.
  • As an experienced people leader, Markus is passionate about building and developing the skills and experience of his cross-functional teams.

Abcam appoints Markus Lusser as new President

Retrieved on: 
Monday, March 18, 2024

CAMBRIDGE, England, March 18, 2024 /PRNewswire/ -- Abcam today announced the appointment of Markus Lusser as President.

Key Points: 
  • CAMBRIDGE, England, March 18, 2024 /PRNewswire/ -- Abcam today announced the appointment of Markus Lusser as President.
  • A seasoned Danaher executive, Markus joins Abcam at a pivotal moment as the company transitions into the Danaher Life Sciences portfolio.
  • Prior to joining Danaher, Markus was responsible for large global commercial organizations, including 20 years at Siemens Healthineers.
  • As an experienced people leader, Markus is passionate about building and developing the skills and experience of his cross-functional teams.

DCN Dx Bolsters Board with Appointment of Former Meridian Biosciences CEO Jack Kenny

Retrieved on: 
Tuesday, March 12, 2024

CARLSBAD, Calif., March 12, 2024 /PRNewswire/ -- DCN Dx, a global leader in the end-to-end development, manufacturing, and commercialization of point-of-use tests, announces the appointment of industry veteran Jack Kenny to its board of directors.

Key Points: 
  • CARLSBAD, Calif., March 12, 2024 /PRNewswire/ -- DCN Dx, a global leader in the end-to-end development, manufacturing, and commercialization of point-of-use tests, announces the appointment of industry veteran Jack Kenny to its board of directors.
  • With more than 30 years of experience in operational and commercial leadership in healthcare and medical device sectors, Kenny is set to bring invaluable expertise to the DCN Dx board.
  • Kenny currently serves as an independent director for Quantum Si and as Chairman of the Board at Biomerica.
  • Upon his appointment to DCN Dx's board, Kenny said, "During my time at Meridian, we collaborated closely with the DCN Dx team.

InkSpace Imaging makes their advanced MRI coils available to Siemens Healthineers Magnetom Scanners

Retrieved on: 
Friday, March 8, 2024

PLEASANTON, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- InkSpace Imaging proudly announces a major leap forward in advancing diagnostic imaging capabilities.

Key Points: 
  • PLEASANTON, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- InkSpace Imaging proudly announces a major leap forward in advancing diagnostic imaging capabilities.
  • Today, the company revealed the successful certification of its groundbreaking Snuggle ™ and Silhouette™ MRI body arrays for compatibility with all Siemens Healthineers TIM 4G 3T Magnetom MRI scanners in the United States.
  • The blanket-like MRI coils offer an unparalleled patient experience, designed to alleviate anxiety, reduce the need for sedation, and minimize additional procedures.
  • We are thrilled that our patient-focused MRI coils are now accessible to all Siemens Healthineers 3T MRI scanner sites in the US."

Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, March 7, 2024

TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported financial results for the fourth quarter and full year ended December 31, 2023.
  • Fourth quarter 2023 revenue increased 60% from approximately $1.3 million in the same three-month period a year ago.
  • G&A expenses for the 2023 fourth quarter increased by 41% to approximately $3.0 million, compared with approximately $2.1 million in the same period in 2022.
  • Fourth quarter 2023 S&D expenses increased by 74% to approximately $2.9 million, compared with $1.7 million in the fourth quarter of 2022.

Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure

Retrieved on: 
Tuesday, February 27, 2024

TULSA is a “one-and-done” procedure, performed in a single session that takes a few hours, and no hospital stay is required.

Key Points: 
  • TULSA is a “one-and-done” procedure, performed in a single session that takes a few hours, and no hospital stay is required.
  • At less than 7,700 Lbs and 80 inches high, MAGNETOM Free.Max is the most lightweight, compact whole-body scanner ever offered by Siemens Healthineers.
  • I commend the teams at Siemens Healthineers and Profound as they work to achieve the convergence of their respective diagnostic and interventional MR technologies.
  • We look forward to collaborating with Profound to help expand access to TULSA as well.

Industry Leaders Announce the Cardiac PET Industry Coalition (CPIC)

Retrieved on: 
Tuesday, March 5, 2024

WILMINGTON, Del., March 5, 2024 /PRNewswire-PRWeb/ -- Leading manufacturers in cardiac positron emission tomography (PET) imaging launched the Cardiac PET Industry Coalition (CPIC), an initiative dedicated to promoting federal policies that advance health outcomes for patients with cardiovascular disease and the availability of cardiac PET diagnostics. CPIC will champion fair and transparent coverage and reimbursement policies that facilitate access to cardiac PET, align practitioners with regard to research opportunities, highlight the clinical and economic benefit of this modality, and provide expanded opportunities to educate healthcare providers and policymakers on the overall value of cardiac PET.

Key Points: 
  • WILMINGTON, Del., March 5, 2024 /PRNewswire-PRWeb/ -- Leading manufacturers in cardiac positron emission tomography (PET) imaging launched the Cardiac PET Industry Coalition (CPIC) , an initiative dedicated to promoting federal policies that advance health outcomes for patients with cardiovascular disease and the availability of cardiac PET diagnostics.
  • "The clinical benefits of cardiac PET imaging are well-documented for making patient care and treatment decisions.
  • "I'm proud of the work the Coalition is doing to increase awareness, maintain appropriate reimbursement and expand the adoption of cardiac PET imaging."
  • Phil Cranmer, Cardiac PET Industry Coalition (CPIC), 1 (215) 888-0040, [email protected] , https://cpicoalition.com/
    View original content to download multimedia: https://www.prweb.com/releases/industry-leaders-announce-the-cardiac-pet...